Publikacje

Rok:   2020   2019   2018   2017   2016   2015   2014   2013   2012   2011   2010   2009

1. Lau R, Du L, Chen E, Fu C, Gould R, Marczyk M, Sinn BV, Layman R, Bedrosian I, Valero V, Symmans WF: Technical validity of a customized assay of sensitivity to endocrine therapy using sections from fixed breast cancer tissue. Clinical Chemistry 2020, in press

2. Qing T, Mohsen H, Marczyk M, Ye Y, O'Meara T, Zhao H, Townsend J, Gerstein M, Hatzis C, Kluger Y, Pusztai L: "Germline variant burden in cancer genes correlates with age at diagnosis and somatic mutation burden". Nature Communications 2020, 11, p. 2438

3. Scheuermann Lisa, Pei Gang, Domaszewska Teresa, Zyla Joanna, Oberbeck-Müller Dagmar, Bandermann Silke, Feng Yonghong, Ruiz Moreno Juan Sebastian, Opitz Bastian, Mollenkopf Hans-Joachim, Kaufmann Stefan and Dorhoi Anca. Platelets Restrict the Oxidative Burst in Phagocytes and Facilitate Primary Progressive Tuberculosis, 2020. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE doi.org/10.1164/rccm.201910-2063OC

4. Abramowicz Agata, Łabaj Wojciech, Mika Justyna, Szołtysek Katarzyna, Ślęzak-Prochazka Izabella, Mielanczyk Łukasz, Story Michael D., Pietrowska Monika, Polański Andrzej and Widłak Piotr. MicroRNA Profile of Exosomes and Parental Cells is Differently Affected by Ionizing Radiation, 2020. RADIATION RESEARCH

5. B. Frey, J. Mika, K. Jelonek, L. Cruz-Garcia, C. Roelants, I Testard, N. Cherradi, K. Lumniczky, S. Polozov, A. Napieralska, P. Widlak, U. Gaipl, C. Badie, J. Polanska, and S.M. Candéias: Systemic modulation of stress and immune parameters in patients treated for prostate adenocarcinoma by intensity modulated radiation therapy or stereotactic ablative body radiotherapy. Strahlentherapie und Onkologie, 2020, doi: 10.1007/s00066-020-01637-5

6. Kimi Drobin, Michal Marczyk, Martin Halle, Daniel Danielsson, Anna Papiez, Traimate Sangsuwan, Annika Bendes, Mun-Gwan Hong, Ulrika Qundos, Mats Harm-Ringdahl, Peter Wersäll, Joanna Polanska, Jochen M. Schwenk and Siamak Haghdoost: Molecular profiling for predictors of radiosensitivity in patients with breast or head-and-neck cancer. Cancers, 2020, 12(3):753

7. Karol Jelonek, Aleksandra Krzywon, Patrycja Jablonska, Ewa M. Slominska, Ryszard T. Smolenski, Joanna Polanska, Tomasz Rutkowski, Jolanta Mrochem-Kwarciak, Krzysztof Skladowski and Piotr Widlak: Systemic Effects of Radiotherapy and Concurrent Chemo-Radiotherapy in Head and Neck Cancer Patients – Comparison of Serum Metabolome Profiles, Metabolites, 2020, 10(2):60; doi:10.3390/metabo10020060

8. Agnieszka Toma-Jonika, Patryk Janus, Joanna Korfanty, Marek Chadalski, Katarzyna Mrowiec, Piotr Widłak, Natalia Vydra, Anna Paszek, Marek Rusin, Joanna Polanska, Wiesława Widłak, Pro-death signaling of cytoprotective Heat Shock Factor 1: up-regulation of NOXA leading to apoptosis in heat-sensitive cells. Cell Death and Differentiation, 2020, doi: 10.1038/s41418-020-0501-8

9. Marczyk M, Jaksik R, Polanski A, Polanska J: GaMRed – adaptive filtering of high-throughput biological data. IEEE/ACM Transactions on Computational Biology and Bioinformatics, 2020, 17(1):149-157, doi: 10.1109/TCBB.2018.2858825

10. O’Meara T, Marczyk M, Qing T, Yaghoobi V, Blenman K, Cole K, Pelekanou V, Rimm DL, Pusztai L: Immunological differences between immune-rich estrogen 1 receptor-positive and immune rich triple-negative breast cancers. JCO Precision Oncology 2020, in press

11. Abu-Khalaf MM, Aderhold K, Marczyk M, Chung G, Hofstatter E, Sanft T, Silber A, DiGiovanna M, Zelterman D, Pusztai L, Hatzis C: Neoadjuvant aromatase inhibitor therapy plus the mTOR inhibitor everolimus in postmenopausal women with hormone receptor positive/HER2 negative breast cancer and an oncotype Dx recurrence score (≤25). Cancer Research 2020, 80(4 Supplement), P5-13-02. Proceedings of the San Antonio Breast Cancer Symposium, San Antonio, TX, USA, December 10-14, 2019

12. Blenman KRM, Li X, Marczyk M, O'Meara T, Yaghoobi V, Gunasekharan V, Park T, Rimm D, Pusztai L: Predictive markers of response to durvalumab concurrent with nab-paclitaxel and dose dense doxorubicin cyclophosphamide (ddAC) neoadjuvant therapy for triple negative breast cancer (TNBC). Cancer Research 2020, 80(4 Suppleement), P3-09-05. Proceedings of the San Antonio Breast Cancer Symposium, San Antonio, TX, USA, December 10-14, 2019

13. Zebrowska A, Gawin M, Marczak L, Sharma P, Mika J, Polanska J, Ferrone S, Kirkwood J, Widlak P, Whiteside T, Pietrowska M, Metoda immunowychwytywania w ocenie molekularnego profilu subpopulacji egzosomów CSPG4+ uwalnianych przez komórki czeraniaka, VII Śląskie Spotkania Naukowe, 29-30.05.2020, Gliwice, pp. 21-22